In contrast, the dysfunction regulation of adiponectin and its receptors has been observed in the development of various diseases, including obesity, insulin resistance, type 1 and type 2 diabetes, and chronic kidney disease [29]. Here, ADIPOQ is linked to type 2 diabetes mellitus.